Order Article Reprints

Seki JT, Sakurai N, Moldenhauer S, Dam J, Atenafu EG, Yip PM, Mazzulli T, Henderson T, Pendergrast J, Cserti C, et al. Human Albumin Eye Drops as a Therapeutic Option for the Mmanagement of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting. Current Oncology. 2015; 22(5):357-363. https://doi.org/10.3747/co.22.2620

Seki, J.T., N. Sakurai, S. Moldenhauer, J. Dam, E.G. Atenafu, P.M. Yip, T. Mazzulli, T. Henderson, J. Pendergrast, C. Cserti, and et al. 2015. "Human Albumin Eye Drops as a Therapeutic Option for the Mmanagement of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting" Current Oncology 22, no. 5: 357-363. https://doi.org/10.3747/co.22.2620

Seki, J. T., Sakurai, N., Moldenhauer, S., Dam, J., Atenafu, E. G., Yip, P. M., Mazzulli, T., Henderson, T., Pendergrast, J., Cserti, C., Velazquez, J. P., Simpson, R., Felluga, G., Messner, H. A., & Lipton, J. H. (2015). Human Albumin Eye Drops as a Therapeutic Option for the Mmanagement of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting. Current Oncology, 22(5), 357-363. https://doi.org/10.3747/co.22.2620